Interim Chief Executive appointed to lead BioFactory [NZ]
Friday 5 Jun 2026
New Zealand’s first BioFactory, which once
established will be a commercial scale shared facility in which biomass
feedstocks are transformed into high value biomaterials, has
appointed Claire Stewart as Interim Chief Executive Officer to guide the
project through its next phase.
Stewart will work part time in the role for an initial six-month
period, providing continuity of leadership and maintaining momentum
while the BioFactory completes its transition to a long-term ownership
and governance structure. This arrangement ensures the BioFactory
maintains senior leadership while remaining disciplined on costs during
this transition period.
BioFactory Interim Board Chair Steve Wilson
says Stewart brings proven experience in innovation, forestry
and technology and a practical track record in leading complex
programmes that rely on strong cross sector partnerships.
“Claire is highly regarded across the forestry sector and the
wider bioeconomy community. She understands what it takes to take
innovation into real world use and has a strong record of building the
partnerships and governance needed to deliver.” Wilson says.
Stewart currently leads the Precision Silviculture
Programme at Forest Growers Research, where she works with
forest growers and research partners to lift value and performance
across the forestry supply chain. Her appointment as part-time Interim
CEO of the Biofactory alongside her current role is supported by Forest
Growers Research and its parent body, the New Zealand Forest Owners
Association.
Wilson also acknowledged the contribution of outgoing founding Chief
Executive Bart Challis, who was appointed in late 2025 to progress the
establishment phase of the BioFactory.
“Bart has laid critical foundations for this next stage. He has
helped shape the BioFactory’s operating platform, progressed
planning and early delivery work, and strengthened engagement with
partners and stakeholders. Importantly, he has prepared the ground for
the BioFactory to transition to a public private partnership model,
which we expect to be launched before the end of 2026, subject to
completion of the capital raise and governance arrangements,”
Wilson says.
Stewart says she is looking forward to continuing to build momentum
while the BioFactory completes the work needed to move into its long-term structure.
“The BioFactory is a critical piece of enabling infrastructure. It
will help New Zealand businesses turn locally available feedstocks,
including forestry residues and other biomass, into higher value
ingredients and materials that can be trialled and produced at
meaningful scale. My focus is to maintain progress through this
transition and support the project to be investment ready and well
governed for the delivery phase.” Stewart says.
Source & image credit: The BioFactory

|